Location
Boston, MA
Signature
See signatures included in Exhibit 99.1
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bain Capital Life Sciences Investors, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Heartflow, Inc. 10%+ Owner Common Stock 10,448,158 $293,070,831 $28.05 04 Feb 2026 Indirect
SpringWorks Therapeutics, Inc. 10%+ Owner Common Stock 4,831,307 $200,644,180 $41.53 10 Aug 2021 Indirect
NewAmsterdam Pharma Co N.V. 10%+ Owner Ordinary Shares 10,473,913 $199,004,347 $19.00 29 Dec 2023 Indirect
NewAmsterdam Pharma Co N.V. 10%+ Owner Pre-Funded Warrant (right to buy) 1,632,653 $39,999,835 $24.50 13 Dec 2024 Indirect
Solid Biosciences Inc. 10%+ Owner Pre-Funded Warrant (right to buy) 6,444,170 $25,963,561 $4.03 19 Feb 2025 Indirect
Olema Pharmaceuticals, Inc. 10%+ Owner Common Stock 4,300,000 $24,758,970 $5.76 10 Jan 2025 Indirect
Annexon, Inc. 10%+ Owner Common Stock 5,401,926 $24,428,590 $4.52 25 May 2023 Indirect
Solid Biosciences Inc. 10%+ Owner Common Stock 5,034,582 $20,289,365 $4.03 19 Feb 2025 Indirect
RAPID MICRO BIOSYSTEMS, INC. 10%+ Owner Class A Common Stock 8,434,560 $8,345,154 $0.9894 19 Jul 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 2,805,413 $2,328,493 $0.8300 10 Dec 2021 Indirect
SpringWorks Therapeutics, Inc. 10%+ Owner Common Stock 1,106 $45,932 $41.53 10 Aug 2021 Direct
Olema Pharmaceuticals, Inc. 10%+ Owner Pre-Funded Warrant (right to buy) 3,500,000 10 Jan 2025 Indirect
Kyverna Therapeutics, Inc. 10%+ Owner Common Stock 3,163,868 12 Feb 2024 Indirect
Heartflow, Inc. 10%+ Owner Series F Preferred Stock 0 11 Aug 2025 Indirect
Heartflow, Inc. 10%+ Owner Subordinated Convertible Promissory Note 0 11 Aug 2025 Indirect
Kyverna Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 12 Feb 2024 Indirect
RAPID MICRO BIOSYSTEMS, INC. 10%+ Owner Series B1 Preferred Stock 0 19 Jul 2021 Indirect
RAPID MICRO BIOSYSTEMS, INC. 10%+ Owner Series C1 Preferred Stock 0 19 Jul 2021 Indirect

Insider Reports Filed by Bain Capital Life Sciences Investors, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HTFL Heartflow, Inc. 04 Feb 2026 1 -$56,100,000 4 10%+ Owner 06 Feb 2026, 16:58
HTFL Heartflow, Inc. 11 Aug 2025 4 -$3.71 4 10%+ Owner 13 Aug 2025, 16:00
HTFL Heartflow, Inc. 07 Aug 2025 0 $0 3 10%+ Owner 07 Aug 2025, 21:46
SLDB Solid Biosciences Inc. 19 Feb 2025 2 +$29,993,561 4 10%+ Owner 21 Feb 2025, 17:48
OLMA Olema Pharmaceuticals, Inc. 08 Jan 2025 3 +$1,727,370 4 10%+ Owner 13 Jan 2025, 16:34
OLMA Olema Pharmaceuticals, Inc. 08 Jan 2025 0 $0 3 10%+ Owner 13 Jan 2025, 16:31
NAMS NewAmsterdam Pharma Co N.V. 13 Dec 2024 1 +$39,999,835 4 10%+ Owner 17 Dec 2024, 17:05
KYTX Kyverna Therapeutics, Inc. 12 Feb 2024 3 +$9,900,000 4 10%+ Owner 14 Feb 2024, 17:26
KYTX Kyverna Therapeutics, Inc. 07 Feb 2024 0 $0 3 10%+ Owner 07 Feb 2024, 21:23
SLDB Solid Biosciences Inc. 11 Jan 2024 1 +$5,000,005 4 Director, 10%+ Owner 12 Jan 2024, 17:09
NAMS NewAmsterdam Pharma Co N.V. 29 Dec 2023 0 $0 3 10%+ Owner 29 Dec 2023, 17:09
ANNX Annexon, Inc. 25 May 2023 0 $0 3 10%+ Owner 30 May 2023, 21:55
ANNX Annexon, Inc. 25 May 2023 1 +$639,720 4 10%+ Owner 30 May 2023, 21:54
SLDB Solid Biosciences Inc. 02 Dec 2022 0 $0 3 10%+ Owner 05 Dec 2022, 15:51
XLO Xilio Therapeutics, Inc. 08 Dec 2021 4 +$410,161 4 10%+ Owner 10 Dec 2021, 19:33
XLO Xilio Therapeutics, Inc. 26 Oct 2021 0 $0 3 10%+ Owner 05 Nov 2021, 18:26
SWTX SpringWorks Therapeutics, Inc. 10 Aug 2021 1 -$70,250,000 4 10%+ Owner 12 Aug 2021, 20:38
RPID RAPID MICRO BIOSYSTEMS, INC. 19 Jul 2021 5 +$2,000,000 4 10%+ Owner 21 Jul 2021, 16:40
RPID RAPID MICRO BIOSYSTEMS, INC. 14 Jul 2021 0 $0 3 10%+ Owner 14 Jul 2021, 20:02